Evaluation of long-term clinical outcomes after Toric Implantable Collamer Lens implantation.

Abstract

To evaluate the long-term (8-10 years) outcomes of Toric Implantable Collamer Lens (TICL) surgery. Nagoya Eye Clinic, Nagoya, Aichi, Japan. Retrospective observational study. We enrolled patients who underwent TICL surgery from 2005-2009 to correct myopia and myopic astigmatism. The safety, efficacy, predictability, astigmatism correction efficacy, and complications were evaluated using preoperative, 1-year postoperative, and final examination data. We included 133 eyes of 77 patients. At the final visit, the mean uncorrected and corrected visual acuity were -0.01±0.2 and -0.17±0.05, respectively. The mean safety and efficacy indices were 0.91±0.26 and 0.68±0.21, respectively. The manifest astigmatism was -0.45±0.43 D. The mean corneal astigmatism change from 1 year post-surgery to the final visit was 0.40±0.26 D. Of the 38 eyes with a change in corneal astigmatism ≥0.5 D, 30 eyes (78.9%) changed to against-the-rule (ATR) astigmatism, one (2.6%) changed to oblique astigmatism, and seven changed (18.4%) to with-the-rule (WTR) astigmatism. The mean manifest astigmatism change from 1 year post-surgery to the final visit was 0.43±0.52 D. Of the 60 eyes with a change in manifest astigmatism ≥0.5 D, 25 (41.7%) changed to ATR astigmatism, 18 (30.0%) changed to oblique astigmatism, and 17 (28.3%) changed to WTR astigmatism. During follow-up, eight of 133 eyes (6.0%) developed anterior subcapsular cataracts, among which four (3.0%) underwent TICL removal and phacoemulsification and aspiration. No vision-threatening complications occurred. TICL surgery showed good long-term astigmatism-correcting effects, although the long-term uncorrected visual acuity decreased. The procedure was effective in correcting myopia and astigmatism.